Tower Research Capital LLC (Trc) Bellus Health Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$7.14 - $8.53 $3,498 - $4,179	-490 Reduced 4.57%	10,223 $73,000
Q4 2022 Feb 10, 2023	BUY	$8.22 - $10.76 $8,836 - $11,567	1,075 Added 11.15%	10,713 $88,000
Q3 2022 Nov 10, 2022	BUY	$8.95 - $12.0 $68,807 - $92,256	7,688 Added 394.26%	9,638 $103,000
Q2 2022 Aug 15, 2022	BUY	$6.46 - $10.02 $1,996 - $3,096	309 Added 18.83%	1,950 $18,000
Q1 2022 May 12, 2022	BUY	$5.56 - $7.99 $1,662 - $2,389	299 Added 22.28%	1,641 $11,000
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $7,058 - $11,138	1,342 New	1,342 $11,000
Q4 2020 Feb 16, 2021	SELL	$2.27 - $3.3 $20,845 - $30,303	-9,183 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.14 - $12.02 $18,551 - $104,201	8,669 Added 1686.58%	9,183 $21,000
Q2 2020 Aug 13, 2020	BUY	$8.88 - $11.15 $4,564 - $5,731	514 New	514 $5,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.